Researchers from Stanford University's Department of Surgery have created an algorithm that aims to protect operating room team members who perform urgent and emergency operations from COVID-19, and rationally conserve the personal protective equipment they wear.
A global randomized clinical trial for low dose oral Xpovio (selinexor) in hospitalized patients with severe COVID-19 aims to evaluate the drug as a potential treatment option.
GlaxoSmithKline plc. and Vir Biotechnology Inc. are collaborating on research solutions for coronaviruses, including SARS-CoV-2.
Providence Cancer Institute, a part of Providence St. Joseph Health, has launched a phase I study of OncoSec's novel DNA‑encodable, investigational vaccine, CORVax12, designed to act as a prophylactic vaccine to prevent COVID-19.
Janice Cowden, a Florida resident who has metastatic breast cancer and symptoms of the novel coronavirus, has tested negative for COVID-19 after a lengthy process that involved being denied testing multiple times—despite her vulnerable status (The Cancer Letter, March 20).
The American Association for Cancer Research board of directors sent the following letter to congressional leadership March 30.
In a public letter to the American Hospital Association, 54 health care organizations condemned attempts by hospital administrators to muzzle health care workers who speak out against coronavirus caseloads and supply shortages.
The following is a statement from the American College of Surgeons.
Cancer Prevention and Research Institute of Texas has suspended its first cycle of grant applications for fiscal year 2021 for Academic Research, Product Development Research and Prevention Program awards.
